BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
Reprints
Prescriptions for biosimilars of AbbVie's rheumatoid arthritis drug Humira significantly increased after CVS Health Corp. altered its drug coverage to include lower-cost biological alternatives, Axios reports. The market share for Humira biosimilars rose from 5% to 36% within a week of the change. This shift marks one of the first significant efforts to promote biosimilar adoption since Humira lost market exclusivity in January 2023.
1. UnitedHealth reports significant data breach; personal health info compromised
2. Illinois House passes governor’s 'Healthcare Protection Act’
3. UnitedHealth faces scrutiny over size, operations, and cyberattack
4. Walmart to shut down health clinics due to unprofitability
5. Analyst says Cigna, Humana share prices could put merger back on the table
6. UnitedHealth to close Optum Virtual Care amid telehealth decline